Active Biotech AB

NEW
OSTO:ACTI (Sweden)  
kr 0.086 -0.0035 (-3.89%) Apr 23
At Loss
P/B:
2.90
Market Cap:
kr 106.41M ($ 11.00M)
Enterprise V:
kr 82.20M ($ 8.50M)
Volume:
10.25M
Avg Vol (2M):
6.28M
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
10.25M
At Loss
Avg Vol (2M):
6.28M

Business Description

Description
Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 8.6
Equity-to-Asset 0.76
Debt-to-Equity 0.1
Debt-to-EBITDA -0.08
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 47.06
9-Day RSI 51.78
14-Day RSI 51.11
3-1 Month Momentum % -17.53
6-1 Month Momentum % -31.71
12-1 Month Momentum % -62.87

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.4
Quick Ratio 4.4
Cash Ratio 3.08

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -23.9
Shareholder Yield % -28.06

Profitability Rank

Name Current Vs Industry Vs History
ROE % -207.91
ROA % -124.5
ROIC % -274.2
3-Year ROIIC % 157.64
ROC (Joel Greenblatt) % -732.19
ROCE % -188.13

Financials (Next Earnings Date:2025-05-08)

OSTO:ACTI's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Active Biotech AB Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil kr)
EPS (TTM) (kr) -0.055
Beta 3.16
3-Year Sharpe Ratio -0.43
3-Year Sortino Ratio -0.6
Volatility % 92.01
14-Day RSI 51.11
14-Day ATR (kr) 0.010467
20-Day SMA (kr) 0.08243
12-1 Month Momentum % -62.87
52-Week Range (kr) 0.063 - 0.517
Shares Outstanding (Mil) 1,230.16

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Active Biotech AB Filings

Filing Date Document Date Form
No Filing Data

Active Biotech AB Stock Events

Financials Calendars
Event Date Price (kr)
No Event Data

Active Biotech AB Frequently Asked Questions

What is Active Biotech AB(OSTO:ACTI)'s stock price today?
The current price of OSTO:ACTI is kr0.09. The 52 week high of OSTO:ACTI is kr0.52 and 52 week low is kr0.06.
When is next earnings date of Active Biotech AB(OSTO:ACTI)?
The next earnings date of Active Biotech AB(OSTO:ACTI) is 2025-05-08.
Does Active Biotech AB(OSTO:ACTI) pay dividends? If so, how much?
Active Biotech AB(OSTO:ACTI) does not pay dividend.

Press Release

Subject Date
No Press Release